FIELD: medicine.
SUBSTANCE: invention relates to method of treatment or reduction of severity of neurodegenerative disorder, selected from Alzheimer's disease or Parkinson disease in patient, which includes introduction to patient of sodium salt of Compound X.
EFFECT: method is effective for treatment of reduction of symptoms of Alzheimer's and Parkinson diseases by introduction to patient of sodium salt of Compound X, which has high bioavailability.
3 cl, 15 dwg, 12 tbl, 14 ex
Title | Year | Author | Number |
---|---|---|---|
THIAZOLIDINEDIONE SALTS WITH REDUCED AFFINITY TO PPAR FOR TREATMENT OF METABOLIC DISORDERS | 2010 |
|
RU2564661C2 |
NEW METHOD FOR SYNTHESIS OF THIAZOLIDINEDIONE COMPOUNDS | 2011 |
|
RU2593370C2 |
SYNTHESIS OF THIAZOLIDINEDIONE COMPOUNDS | 2011 |
|
RU2594725C2 |
PPAR-SUPPORTING COMPOUNDS FOR TREATING METABOLIC DISEASES | 2014 |
|
RU2687490C2 |
HETEROCYCLIC MODULATORS OF ATP-BINDING CARTRIDGE TRANSPORTER | 2006 |
|
RU2463303C2 |
HETEROCYCLIC MODULATORS OF TRANSPORTERS OF AN ATP-BINDING CASSETTE | 2016 |
|
RU2765714C2 |
HETEROCYCLIC MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | 2012 |
|
RU2608610C2 |
THIAZOLIDINEDIONE ANALOGUES FOR TREATING DIABETES AND DYSLIPIDEMIA | 2008 |
|
RU2486179C2 |
METHODS AND INTERMEDIATE COMPOUNDS | 2010 |
|
RU2531588C2 |
MODULATORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE | 2007 |
|
RU2459821C2 |
Authors
Dates
2015-12-10—Published
2010-12-15—Filed